milestone partnership for both nations and ANTG’s Eve CBD flower will be distributed in New Zealand by NUBU Pharmaceuticals, which is the leading medicinal cannabis distributor in New Zealand. Cantelo spoke about the quality of Australian medicinal cannabis and its reputation in other countries. He said, “This agreement is not only a historic first for New Zealand, but also beneficial for the Australian industry as a whole”.
Cantelo added, “The high benchmarks in Australia for growing and producing medicinal cannabis has set us up as the best in the world. We have a reputation and climate for growing excellent produce in general – it makes sense that we would produce the highest quality medicinal cannabis product as well. Our Kiwi neighbours will also have access to the highest quality Australian flower while their home-grown cultivation industry starts producing.”
Mark Dye, co-founder and CEO of NUBU Pharmaceuticals, expressed his delight at the transaction, which would provide New Zealanders with access to ANTG’s high-quality medicinal cannabis products. Dye expressed delight over the company’s accomplishments. He said, “Being the first company to legally sell cannabis in New Zealand is beyond exciting. I can’t even begin to explain the blood, sweat and tears it has taken to get here”.
Dye added, “I am excited for the patients – they have been calling out for this for decades. I am so proud it is the team at NUBU that has been able to make this happen for them. ANTG are very much leading the Australasian cannabis industry. We are over the moon to have them as a distribution partner.”
